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Abstract 
 
 
 
In this dissertation is proposed a methodology to identify patient’s recovery patterns 
after cardiovascular surgery based on laboratory tests results. The main purpose is to 
enhance the understanding of the manifestations of postsurgical complications in patients 
who underwent cardiovascular surgery. The analysis of patients’ recovery process is 
based on the relationship between plasma calcium, ionized calcium and platelet count 
over time. 
Laboratory results from the James A. Haley Veterans' Hospital databases, related to 
patients admitted to the Surgical Intensive Care Unit (SICU) after cardiac surgery 
(coronary artery bypass, aortic value replacement and mitral valve replacement), are 
used. These databases contain information regarding commonly ordered tests such as 
Complete Blood Count tests (CBC) and Basic Metabolic Panel (BMP) for a large group 
of patients over time.  Physicians usually order these tests as a component of screening, 
routine evaluation, or serial assessment. These test results, contain a large amount of 
information used by most physicians during the diagnosis process and patient monitoring.  
This study creates time series of some components of the aforementioned tests to 
analyze their behavior during the perioperative and postoperative period. Time series 
based clusters are developed to determine the similarities among tests results from four 
different types of patients: patients who had a satisfactory recovery process without any 
manifestation of complications, patients who experienced complications but survived, 
 viii 
 
patients who experienced complications and then died during their recovery and patients 
who died during the perioperative period.  As a conclusion, the time series based 
clustering techniques were able to identify whether a patient is likely to fully recover 
from the surgery, but it does not have the power to detect effectively results 
corresponding to a patient experiencing complications. 
The development of this methodology provides statistical evidence of the differences 
among different patterns on patient recovery. It is clear that patients experiencing 
complications have a steeper drop of test results after surgery, and also a non-stable trend 
towards normal levels.  The appropriate use of the proposed methodology could help to 
timely anticipate complications in patient condition, improve the comprehensiveness of 
the assessment of patient condition based on laboratory test results and enhance the 
utilization of laboratory results databases. 
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Chapter 1: Introduction 
 
 
 
One of the challenges faced by healthcare providers is to develop methodologies to 
effectively monitor patient condition during the cycle of care.  The development of these 
methodologies is important, since their implementation could reduce patient mortality or 
improve their quality of life.  This dissertation addresses the development of a 
methodology to effectively identify common patterns observed in laboratory test results 
over time of patients who underwent cardiovascular surgery. The focus of this study is 
the analysis of laboratory test results during the post-surgical period. 
1.1 Background 
It is estimated that diagnostic laboratory and imaging procedures represent the 
majority of healthcare costs in the U.S. The expenditures on imaging procedures doubled 
from $6.4 billion to $12.0 billion from 2000 to 2005 for just for Medicare’s users [1].  
Nevertheless, the amount of information that is currently extracted from laboratory test 
results is limited, due to the complexity of the interactions among them and the lack of 
effective methods to assist physicians interpreting them.   
Still, laboratory tests are one of the primary sources of information to diagnose and 
monitor the patient’s condition.  Commonly physicians make inferences about patient 
condition based on the most recent test result, ignoring important factors such as the 
patient’s tests history, relationships among different test results and their rate of change.  
Overall, physicians are not trained to perform diagnostics considering sets of multiple 
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attributes that describe a patient’s condition. Yet, in many cases patients present complex 
health scenarios. In the general practice of medicine physicians lack techniques and tools 
that will help them detect temporal changes and hidden interactions among tests results. 
For the most part, physicians depend on their experience and their ability to interpret a set 
of laboratory results to best assess the patient’s current condition, and its possible future 
state.   
It is challenge for healthcare providers to improve the current utilization of tests 
results and imaging procedures to timely identify possible complications in a patient’s 
condition.  This is even more relevant for patients suffering from chronic diseases (i.e. 
heart disease) or patients with a compromised health condition such as those in intensive 
care units (ICUs).  
It is estimated, just in the US, that more than five million patients are admitted to 
intensive care units yearly [2,3], being cardiovascular diseases and post-operatory 
management two of the primary causes.  These two patient populations represent a large 
proportion of the deaths in the U.S.:  10% to 20% of the patients admitted in ICUs died in 
hospitals across the US [2, 3] and 34.3% of the total deaths in the US are caused by 
cardiovascular diseases [4]. 
1.1.1 Challenges in Interpreting Laboratory Test Results 
There is a clear need to update current medical practices of monitoring patients to 
improve outcomes. Identification of postsurgical complications will help physicians to 
assess the likelihood of adverse outcomes, and then decide what interventions could 
improve the condition of the patient.   
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Unfortunately, physicians do not have means that allow them to do prospective 
assessment of the evolution of the patient.  Based on their experience and results from 
different tests, physicians try to assess possible future events that could happen if no-
interventions are done. Also, physicians are given a large set of indicators of patient 
condition (i.e. imaging results, laboratory work, clinical history, etc.) and it is difficult to 
fully extract all the information that is embedded to perform a comprehensive assessment 
of patient condition. There are several tests and the hidden relations among them are not 
easily recognized by the naked eye. It is necessary to develop comprehensive approaches 
that enhance the analysis and interpretation of laboratory test results to give healthcare 
providers the ability to make proper assessment of a patient’s condition over time, 
reducing the occurrence of adverse outcomes. 
At the same time, researchers on the healthcare engineering arena have to be aware 
that the use of complicated techniques to analyze this big spectrum of data could 
complicate the proper interpretation of the outcomes by the physician.  All the decision 
support tools have to be designed with the objective of being interpretable for any 
physician in order to make it easily transferable to any clinic and to improve medical 
decision on healthcare settings.  
All these issues open a broad research field where there are numerous opportunities 
for researches across a variety of disciplines for help healthcare providers to improve 
patient care.  In the next section it is described research opportunities that the author 
explored on this dissertation.  
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1.1.2 Research Opportunities 
Currently, research in healthcare engineering has become one of the most important 
areas to generate high societal impact due to the integration of several areas of knowledge 
to the service of people health improvement.  A variety of multidisciplinary research 
endeavors have been developed lately associated to healthcare.  Many of them have as 
their aims the development medical devices, methodologies to improve disease diagnosis 
processes, analysis of pandemic outbreaks, resource allocation and patient monitoring 
techniques, among others. 
A fundamental opportunity identified by the author is in improving the effectiveness 
of current practices in interpreting laboratory test results, by the development of a 
dynamic approach that improves medical practice in monitoring postsurgical patient 
condition.   
Patient monitoring procedures have been developed basically to follow up patient 
evolution during their stay in hospitalization.  As mentioned before, laboratory tests 
become one of the more used tools to monitor the patient’s health. According to the 
patient’s condition, physicians order different sets of laboratory tests, to either confirm a 
hypothesis about the evolution of the patient or just as a part of a routine screening rule.   
Two common tests order by physicians to perform a general screening of a patient’s 
condition are: Complete Blood Count test (CBC) and Basic Metabolic Panel (BMP).  
These tests are utilized to identify abnormalities in heart rhythm and brain function, as 
well as common conditions such as anemia and infections [5]. 
Given that patients who underwent complicated surgery procedures and patients 
admitted in intensive care units (ICUs) represent a large proportion of the deaths in the 
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US [2, 3], it is critical to develop research endeavors in related to the analysis of 
laboratory test results to improve the monitoring process of these patient populations.  
Based on the indentified opportunities, the objectives that are perused on this research are 
stated in the next section.  
1.2 Research Objectives 
The overall objectives are threefold: (1) to improve the quality of medical inference 
based on the better interpretation of laboratory tests data, (2) to enhance the timely 
identification of postsurgical complications of patients who underwent cardiovascular 
surgery, and (3) to advance the provision of a more personalized patient care.  
As a result, the author expected that practices of postsurgical patient monitoring can 
be enhanced by the development of this multi-test-based approach to guide medical 
inference.  A positive impact may be achieved in improving patient outcomes, reduction 
in patient monitoring cost, decrease of time interpreting tests results and more 
effectiveness in timely identifying patient complications.  
1.3 Brief Research Description  
This research proposes a methodology to analyze laboratory test results of patients 
who underwent cardiovascular surgery, to assess their risk of complications and death 
during each phase of the recovery cycle. The population included on this study is 
composed by patients admitted at surgical intensive care unit (SICU) after undergoing 
coronary artery bypass, aortic value replacement and mitral valve replacement at the 
James A. Haley Veterans' Hospital (JAHVA), Tampa, Florida.  The VA system is largest 
healthcare delivery network in the US and has a significant historical dataset of medical 
records, probably the most comprehensive in the country.  In addition, the JAHVA is the 
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busiest facility in the VA system due to the number of active soldiers that are referred to 
JAHVA. This provides a tremendous opportunity to have significant national impact and 
potential transformed the way laboratory results are analyzed when providing medical 
care to patients. 
The analysis considers the characterization of the behavior of commonly ordered 
laboratory tests to monitor patient condition during the postsurgical period.  Initially, the 
author applied non-parametric statistics to determine differences on the behavior of these 
results across patients who experiences complications and patient who did not.  Also, a 
time series of laboratory test results was constructed to first identify different laboratory 
result patterns and then generate patient recovery profiles over time based on the 
decomposition of the time series in segments that represent different stages on the 
patient’s recovery cycle.  Several mathematical and statistical techniques are used to 
achieve this goal, including time series clustering, data mining, fuzzy logic, among 
others.  
1.4 Organization of the Dissertation 
The remainder of this dissertation is organized as follows:  
 Chapter 2 contains relevant literature review. The chapter describes current practices 
in interpreting laboratory test results, and the analysis of the importance of commonly 
ordered test in monitoring patient condition.  This section also shows a description of 
techniques for the analysis of time series, clustering and fuzzy logic. 
 Chapter 3 describes the research problem, description of the proposed approach and 
the identification of challenges in interpreting laboratory tests results as a dynamic 
function.  
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 Chapter 4 describes the dataset construction process as well as the design, evaluation, 
and validation of the proposed methodology for the analysis of laboratory tests 
results.  
 Chapter 5 describes the performance of the proposed methodology for the analysis of 
laboratory test results. Also an analysis of considerations for practical use of the 
methodology is presented as well as guidelines for the user. 
 Chapter 6 concludes the dissertation by describing the expected benefits after the 
implementation of the proposed methodology. It also describes possible directions for 
future work. 
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Chapter 2: Literature Review 
  
 
 
Chapter 2 contains relevant literature review. The chapter describes current practices 
in interpreting laboratory test results, and the analysis of the importance of commonly 
ordered tests in monitoring a patient’s condition. This section also shows a description of 
techniques for the analysis of time series, clustering and fuzzy logic. 
To better understand the value of research in improving the methodologies to 
interpret laboratory test results, it is necessary to identify which are current practices used 
by physicians and the relevant work that supports it.  The next sections describe relevant 
work and techniques that are used to interpret laboratory test results and time series data 
in healthcare and in other industries. 
2.1 Analysis of Laboratory Test Results: Current Practice  
Development of standards for the analysis of blood test indicators is based on the 
records from laboratories’ patient population or by recruiting a group of reference 
subjects classified as ―healthy‖.  Reference ranges are commonly created based on results 
from the healthy population of an institution, including the values that correspond to the 
95% (µ ± 2 standard deviations) of the results.  This guideline relies on the fact that 
several reference ranges are proven to follow a normal distribution [6]. However, there is 
not an agreement on the methodology to determine these standards, resulting in method-
dependent standards, and as a consequence, reference values vary across clinical 
laboratories [6] i.e., a survey of 525 clinical laboratories showed that the reference range 
 9 
 
of total plasma calcium varies from 8.3 to 8.8 milligrams per deciliter as the lower limit, 
and from 10.2 to 10.7 milligrams per deciliter for the upper limit [7].  
Methodologies to develop reference ranges are sometimes difficult to deploy due to 
the time needed to collect samples, cost and knowledge needed to validate the results [8]. 
There are two basic reference ranges: health-associated and decision based ranges [9].  
Health associated ranges are based on subjects in good health condition while decision 
based ranges are based on limits that characterize a specific medical condition or 
determines an intervention.  
Notice that, even for homogenous populations, the behavior of the human body 
differs among individuals.  Existing reference ranges are used to identify abnormalities in 
the patients’ test results without really knowing what a normal result is for a specific 
patient, even when historical data about laboratory results is available, presenting a 
challenge to healthcare providers to improve personalized healthcare delivery practices. 
Unfortunately, these techniques mostly rely on the fact that single data points can be 
an indicator of a condition or as a decision guideline to order an intervention, ignoring 
what is happening to the patient over his/her cycle of care.  Same laboratory test results 
can be an indicator of different stages on the progression of a specific disease: for 
example, figure 2.1 shows plasma calcium results for two patients during their 
postoperative recovery in ICUs.     
Cases like this could be often observed in medical practice.  It is important to include 
in the analysis of laboratory test results a temporal component that really captures what is 
happening over time.  This will allow physicians to have a more complete patient profile 
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since they can compare if the result is normal according to the stage on the patient cycle 
of care, and not only according to the corresponding reference range. 
 
Figure 2.1 Plasma calcium results for two patients during their recovery in ICUs 
 
 2.2 Patient Monitoring Techniques  
This section presents a review of relevant research associated to monitoring 
techniques of patients with heart disease or patients who underwent cardiovascular 
surgery.  
Research efforts in monitoring patient condition of patients suffering heart disease 
reveal that four major aspects have been typically addressed: (1) understand physician’s 
decision making process, (2) determine effective measures to assess patient health 
condition and (3) modeling and predicting patient outcomes (i.e. logistic regression 
approach) [18, 19, 20, 21, 22, 23].   
There is a body of work related to the analysis of the relationship of patient 
demographics and the differences in patient health. However, one aspect that has been 
not addresses commonly is the differences in physician’s decision making process that 
causes differences in the prescribed medicines or the disease management decisions.  
6
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Aspects like physician’s education, culture or age could influence these differences.   
Differences iin physician’s diagnosis have been studied for patients suffering coronary 
heart disease (CDH) [10].  In this study, the authors designed a factorial experiment to 
test how four indicators affected physicians’ decisions regarding the diagnosis of CHD.  
256 physicians were included on the study in a randomized manner.  As a result, the 
authors found that patient’s gender is one of the aspects that biased physicians’ decisions.  
However, factors such as social class and race did not have a significant influence.   
Other studies describe different factors that causes that physicians make suboptimal 
diagnostic and decisions about treatments [11].   The main conclusion of this study is that 
many of the listed biases affect, in the medical practice, how they gather and use 
evidence while performing diagnoses. This situation could cause deficiencies in 
healthcare delivery such as patient mismanagement, incorrect diagnosis and adverse 
outcomes.  Arnold and Anderson [45] stated that it is normal that physicians, like any 
other person, have biases in their reasoning and the best strategy to mitigate their effect 
on the decision making process is to make them aware that biases are always present, so 
they can avoid them.  As evidence of the positive effect of educating physicians about 
biases in medical decision making, Gruppen et al. [46] found that physicians of an 
institution were informed about the tendency to overestimate the likelihood of good 
outcomes rather than adverse outcomes.  
A common bias found in the literature, documented by Bornstein [47],   is the 
tendency of physicians to stick with a treatment even though the patient does not show 
any improvement.   Among the reasons that may be associated to this practice are: to the 
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time invested on the patient, the treatment has been used for years in medical practice, 
and for similar patients the treatment has worked successfully.   
As a consequence of biases during patient diagnosis and monitoring, the evidence-
based-medicine approach has become an alternative to avoid falling on biased diagnosis 
[48,49].  Evidence-based-medicine is an approach that combines experiences from 
multidisciplinary teams and patients to perform better disease diagnosis and management 
[50].   By using objective information from the experiences of all clinical personnel, 
several sources of bias can be mitigated.   One of the most important is physicians’ 
intuition what makes them to use just some pieces of information to make inferences 
about a patient condition.   
This issue in medical practice makes the author believe that there are commonly used 
―rules of thumb‖ that may be bias based on physicians’ believes.  This can be observed in 
current practices in interpreting laboratory test results. It is commonly assumed 
relationships between blood test results such as albumin and ionized calcium [51], 
ignoring their relationship with other indicators.   
Several researches have also identified the need to determine effective measures to 
assess patient health condition.  This process is conducted to validate a hypothesis related 
to the relationship of an indicator with the presence of a condition on a patient. On this 
matter there are standard tests (i.e. glucose level and the presence of diabetes, or platelet 
count and hemophilia) but rarely physicians assess patient condition by comprehensively 
considering multiple tests as markers of a specific condition.  For patients with co-
morbidities it is more complicated to perform an accurate assessment of what exactly an 
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indicator is showing and, even more critical and difficult to identify, in which stage of the 
disease is the patient [12, 13, 14, 15, 16, 17] 
Analyzing laboratory test results, including their temporal variation, become a 
difficult task for physician due to the fact that there is a lack of techniques and tools that 
will help them detect changes and hidden interactions among tests results over time.  
Most of the work on this area analyzed patient condition using univariate measures and 
static data.     
There is extensive literature discussing methodologies to improve patient monitoring 
procedures, but without simultaneously consider relevant aspects such as the effect of 
time, multivariate indicators of patient condition or laboratory tests history.   In general, 
modeling patient disease progression overtime and patient monitoring can be achieved by 
using time series analysis.  One of the most common techniques to monitor patient 
condition is following patient’s heartbeat. Time series analysis has been utilized to 
determine differences between the heartbeat of healthy patients and patients with severe 
congestive heart failure [52], a young healthy patient population versus an elderly 
population [53], patients suffering from coronary artery disease with healthy patients 
[53], and for the characterization of patients suffering from epilepsy [54].    
Time series has also used to study variations on laboratory test results, such as 
creatine [55].   Time series has also used to monitor routine diagnostic test data from for 
patients with severe influenza (AH1N1) to elaborate strategies for its control [55].  
However there are not extensive studies for the analysis of laboratory tests to monitor 
patient condition during their hospitalization time.   
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Although laboratory tests are used for general screening purposes in medical practice, 
the characterization their tendencies overtime are not clearly stated in the literature.  
However, modeling disease progression has been studied for multiple sclerosis [27] and, 
mostly for detection of influenza pandemic outbreaks [55, 56, 57].  Although there are 
books and extensive literature review about methods to interpret temporal data and 
biostatistics [28], there are not applications related to the use of laboratory test results to 
monitor patient condition in ICUs.  
There are other techniques, such as Markov models and functional analysis[31, 32], 
used to modeling disease progression [30] and screening, such as aortic aneurysm [29], 
severe crohn’s disease [58,59], hepatitis C [60],  infectious diseases [61], breast cancer 
[62], prostate cancer [63], among other applications.    
The analysis of laboratory test results presents a challenge, due to their multivariate 
nature (components of CBC and BMP) and the non-standardized sampling process.  
Unfortunately, the test results data is not uniformly sampled due to the lack of a 
standardized sampling procedure. The periodicity of the sampling is determined by the 
physician, which complicates a direct comparison of the patients’ evolution. 
In other areas of knowledge, authors have done the analysis of similar data using 
multivariate approaches for a numerous applications with the objective of characterizing 
patients into clusters [24, 25, 26]. 
2.3 Similarities among Patients’ Recovery Cycle 
Several authors have applied clustering methods to find similarities among elements 
of a population. General clustering methods are modified to be applicable to dynamic 
environments (i.e. k-means, c-means, agglomerative hierarchical method) for diverse 
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purposes [33, 34, 35].   The variation on these methods from their original form is based 
on the replacement of similarity measures for static data with an expression for dynamic 
data [36].   Commonly used similarity measures are Euclidean distance [25, 33, 35], 
Pearsons’ correlation coefficient [36] and Kullback-Lieber distance [35]. The objective is 
to maximize the sum of similarity measures between elements within a cluster [36]. 
Hard-partition-based [24, 34], fuzzy [33, 35, 37] and wavelet-based algorithms [38], 
among other techniques, are also used to create time series clusters.  However, none of 
these techniques has shown an optimal procedure to estimate the total number of clusters 
[36].  It is necessary to develop an approach to efficiently capture underlying patterns of 
medical data that could help physicians obtain valuable information about patients’ risk 
of complications and improve the quality of healthcare delivery. 
2.4 Commonly Ordered Laboratory Tests 
Laboratory tests are ordered by doctors as one of the sources to diagnose patients' 
diseases and as a component of health condition progression. The most common blood 
tests are the CBC and the BMP.  
2.4.1 Complete Blood Count (CBC) 
This test is compounded by a set of indicators such as red blood count, white blood 
count, hemoglobin, hematocrit, and platelet count. The first four indicators are the main 
reason to order a CBC, since they provide information to perform a general screening of 
patient condition. 
On the other hand, platelet levels are commonly tested before surgery and during the 
procedure to test the ability of the human body to heal wounds and traumas generated by 
the surgery. Platelets are cell fragments circulating in the blood stream and involved in 
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the cellular mechanisms leading to the formation of blood clots. Dysfunction or low 
levels of platelets predispose the body to bleed. On the other hand, high levels may 
increase the risk of thrombosis. Treatment to control platelet count could vary among 
patients regarding to the severity of the disorder. It is noticed that if the detected amount 
of platelets is slightly higher (or lower) than the acceptable limits, the intervention would 
be different if the gap between those two is huge. It is necessary to develop a model to 
analyze these dynamics to prevent possible adverse events and improve patient care 
delivery. 
Currently, doctors compare the results of platelets with its reference range. The 
reference range is an interval used by doctors to compare whether a test result is 
considered normal or not. Reference ranges usually consider 95% of the expected results 
of a healthy population within its bounds. Unfortunately, doctors just realize that the 
platelet count is low, or high, after the test, without having a system that helps them to 
identify these complications in advance. The development of techniques that allow 
doctors to anticipate dangerous levels of platelets will help in preventing the occurrence 
of adverse events. 
2.4.2 Basic Metabolic Panel (BMP) 
The analysis of the components of the BMP provides important information regarding 
fluid balance in the human body, particularly electrolytes.  In general, measuring 
electrolytes is useful in monitoring vital normal functions such as heart rhythm and 
neuromuscular function [6 and 7]. Some of the known conditions related to fluid balance 
are muscle weakness, kidney disease, and heart disease.  Specifically, calcium level is the 
related to bone, teeth healthiness, muscle function, nerve function and blood clotting.    
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Calcium is found in the human body in three forms, physically complexed in the 
bones, ionized (free in the blood stream) and bound to proteins, mostly plasma albumin.   
The level of calcium is known to be associated to the level of plasma albumin, a protein 
that constitutes 60% of plasma proteins [8].  The level of plasma calcium is considered 
normal if it falls within 8.5 - 10.5 mg/dl.  Even when there is a disorder in the plasma 
albumin, physicians have developed an estimate of the plasma calcium, called corrected 
calcium [9].  This expression has been proven to be a rough estimate [10 and 11], but it is 
still used in practice.   
Although, there is a relationship between plasma calcium and plasma albumin, 
changes in plasma calcium could also be influenced by the variation in ionized calcium.  
The ionized calcium is the metabolically active form of calcium that is available in the 
blood for interactions in the cells, but is not often measured in clinical use, largely by 
tradition.  Physicians order the arterial blood gas test, mostly to check conditions such as 
oxygenation problems, acid-base disorders, and breathing difficulties [12].  Normal levels 
of ionized calcium are between 1.1-1.4 mmol/L.  Ionized calcium is not altered by 
changes in plasma albumin, and it is generally believed that, ionized calcium is quite 
stable and not altered acutely, although this study will investigate whether that belief is in 
fact correct. 
Based on preliminary observations, both plasma calcium and ionized calcium seem to 
manifest a noticeable and sustained decrease after cardiovascular surgery. This behavior 
appears to be a component of the negative acute phase response, and it appears to occur 
regularly in the patient cohort that underwent this type of surgery.  Figure 2.2 shows the 
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patients’ average plasma calcium and ionized calcium during the first three days after 
surgery, being zero the day of surgery.  
 
Figure 2.2 Plasma calcium and ionized calcium patterns after surgery 
 
It is noticeable that both indicators fall dramatically after surgery, to levels that would 
usually be considered quite low, but without any clinical manifestations in the patients.  
However, if plasma calcium turns out to be a good marker of patient recovery, its 
behavior is expected to be different for patients who experienced complications.  The 
next chapter presents a description of the methods used in this research to analyze the 
plasma calcium patters during the patients’ recovery cycle.   
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Chapter 3: Description of the Proposed Approach to the Analysis of Postsurgical 
Laboratory Tests Results 
 
 
 
The population used in this study is composed by 305 patients admitted to the SICU 
of the JAHVA after undergoing cardiovascular surgery.  The researchers used de-
identified data to conduct the study, following the requirements established by IRB, 
JAHVA R&D and HIPAA for such a study.  The dataset contained information about 
patients’ clinical history including date of admission, surgery type, date of surgery, date 
of discharge and a complete history of laboratory tests results.  Accurate dates and times 
were required in order to establish the time series basis of the data, but all identifying 
information was excluded.  A description of the assumptions and methods used to 
analyze the data are presented in the next sections. 
3.1 Surgical Procedures (Interventions) 
Patients who underwent cardiovascular surgery were identified using a database 
search based on assigned ICD-9 codes (International Classification of Diseases) [13] (see 
table 3.1).  The ICD-9 codes provide a classification for diseases, symptoms, 
abnormalities and causes of a disease.  This classification assigns each disease to a 
unique category and code.  The World Health Organization (WHO) published these 
codes as a guideline to compare diseases and symptoms around the globe. 
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Twenty four cardiovascular procedures were included in this study; they are listed on 
table 3.1. All patients undergoing one of the identified procedures during the time period 
January 2006 to April 2008 were included. 
 
Table 3.1 ICD-9 codes of the cardiovascular procedures included in the study 
 
ICD – 9 
Codes  
Bypass Procedures 
36.10 
Aortocoronary bypass for heart revascularization, not 
otherwise specified 
36.11 (Aorto)coronary bypass of one coronary artery 
36.12 (Aorto)coronary bypass of two coronary arteries 
36.13 (Aorto)coronary bypass of three coronary arteries 
36.14 (Aorto)coronary bypass of four or more coronary arteries 
36.15 Single internal mammary-coronary artery bypass 
36.16 Double internal mammary-coronary artery bypass 
36.17 Abdominal-coronary artery bypass 
36.19 Other bypass anastomosis for heart revascularization 
39.22 Aorta-subclavian-carotid bypass 
39.23 Other intrathoracic vascular shunt or bypass 
39.24 Aorta-renal bypass 
39.25 Aorta-iliac-femoral bypass 
39.26 Other intra-abdominal vascular shunt or bypass 
39.28 Extracranial-intracranial (EC-IC) vascular bypass 
39.29 Other (peripheral) vascular shunt or bypass 
ICD - 9 
Codes 
Mitral Valve Procedures 
35.02 Closed heart valvotomy, mitral valve 
35.12 Open heart valvuloplasty of mitral valve without replacement 
35.23 Replacement of mitral valve with tissue graft 
35.24 Other replacement of mitral valve 
ICD - 9 
Codes 
Aortic Valve Procedures 
35.01 Closed heart valvotomy, aortic valve 
35.11 Open heart valvuloplasty of aortic valve without replacement 
35.21 Replacement of aortic valve with tissue graft 
35.22 Other replacement of aortic valve 
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Initially, the surgical procedures and their corresponding dates were identified. 
Subsequently, the surgery dates were used as a common time reference for the analysis of 
the postsurgical period for each patient.  Finally the surgery date for all the patients was 
defined as ―time reference zero‖, delineating the beginning of the post-surgical period.   
3.2 Reference Ranges 
The behavior of the laboratory test results differ among individuals, even for 
homogeneous populations.  To address this issue, physicians use reference ranges to 
determine if a specific test result is considered normal [14 and 15].  
Reference ranges are commonly created based on results from the healthy population 
of an institution, including the values that correspond to 95% (mean ±2 standard 
deviations) of the results.  This guideline relies on the fact that several reference ranges 
are proven to follow a normal distribution [15].   For the purpose of this study, existing 
reference ranges for laboratory test results are used to identify abnormalities in the test 
results.   
There is not agreement on the appropriate methodology to determine these standards, 
resulting in method-dependent standards, and as a consequence, reference values vary 
across clinical laboratories [16] i.e. a survey of 525 clinical laboratories showed that the 
reference range of total plasma calcium varies from 8.3 to 8.8 milligrams per deciliter as 
the lower bound, and from 10.2 to 10.7 milligrams per deciliter for the upper bound [17].    
The authors developed reference ranges for the actual population used in this study 
using historical plasma calcium data (preoperative).  The most recent preoperative value 
is used as a baseline to reference the postoperative values. 
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  3.3 Patient Population 
The American College of Surgeons National Surgical Quality Improvement Program 
(ACS NSQIP) is ―the first nationally validated, risk-adjusted, outcomes-based program 
to measure and improve the quality of surgical care‖ [18].  Hospitals participating in the 
program have access to different reports and support that help them make informed 
decisions and provide better healthcare delivery.  As a part of this program, the JAHVA 
collects information about the evolution and outcomes of all patients undergoing 
cardiovascular surgery.   
Each patient record is reviewed and abstracted by a trained surgical advanced practice 
nurse and the clinical information is integrated with quantitative data extracted from the 
hospital database.  This information will be used to identify which patients, within the 
dataset, had postsurgical complications and which patients died after surgery. The 
patients included in this study are classified in four groups according to their recovery 
cycle and their outcome at the end of the cycle of care.   The four patient types are listed 
below: 
 Type 1. Patients who had a satisfactory recovery process and were discharged without 
any identified complication. 
 Type 2. Patients who survived the perioperative period, had complications during the 
recovery process, but survived and were discharged from the hospital. 
 Type 3. Patients who survived the perioperative period, had complications and then 
died within 30 days after surgery.   
 Type 4. Patients who died during the initial postoperative period (within 4 days after 
surgery)  
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 Excluded. Patients who died intraoperatively were excluded from the study as there 
were no data available for analysis. 
In the study patients who survived to day 30, but then died at a later date (typically 
post-discharge), are not considered as deaths, since they are typically associated a new, 
intercurrent event not present during the period of study.  Examples of postsurgical 
plasma calcium test results for these four groups of patients are shown in figures 3.1 a, 
3.1 b, 3.1 c and 3.1 d:  
 
Figure 3.1 Examples of postsurgical plasma calcium for all patient types 
According to surgeons at the JAHVA, patients who had a satisfactory recovery cycle 
are expected to be sent home approximately within 7 days after surgery.  As it can be 
observed in figure 3.1 a, patients had a fall in plasma calcium, below the lower bound of 
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the reference range, reaching its minimum approximately during the second day after 
surgery.  Then, the plasma calcium starts to go back to levels within the reference range 
until it reaches levels near to the baseline.  The time of recovery is longer for patients 
who experienced complications. This is also reflected in the time required for plasma 
calcium levels to return to normal levels.  For these patients (figure 3.1 b) the continuous 
decrease in the level of plasma calcium reflects the lack of stabilization on patient 
condition.   Type 3 patients (figure 3.1 c) had an initial increase in calcium level, but after 
a few days the plasma calcium fell. On the other hand, patients who died during the initial 
postoperative period show no recovery after the natural drop in plasma calcium. 
In general the analysis of the patterns of laboratory tests results over time could 
provide physicians with valuable information to assess patient recovery and anticipate 
possible complications on patient condition.  In the next section an approach to further 
analyze laboratory test result patterns is presented.  
3.4 Analysis and Characterization of Laboratory Test Results over Time 
Several laboratory test results have a negative acute response to the surgery.  
Physicians in the JAHVA have identified that other test results present an acute response 
after surgery (e.g. platelet count).  For a normal patient, these indicators fall until 
reaching a minimum, commonly below the lower bound of the reference range, and then 
begin to recover normal levels.  
 In the case of plasma calcium, the minimum level is 7.734 mg / dl (mean value for 
the population considered in this study), and then begins to recover its normal levels.  
The time to return back to values within the reference range could vary among patients, 
due to the differences in the recovery cycle.  As a reference, the plasma calcium recovery 
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cycle during the postsurgical period as well as some notations, are described as follows 
(figure 3.2):  
  
Figure 3.2 Plasma calcium recovery cycle 
 
 Drop Phase (DP): the time-span immediately after surgery when the patient’s test 
result level drops significantly until it shows a change in the decreasing trend.  The 
drop phase length is the time between surgery and the initial minimum (a). 
 Recovery Phase (RP):  the time-span from the initial minimum (a), until the time 
when the results reach normal levels.  This phase can be further characterized:  from 
the initial minimum (a) until the test results reach the lower bound of the reference 
range (b) and from the initial minimum (a) until return to the baseline (c).   
 RDP-min:  Minimum result (R) at the end of the drop phase.  
 RG-min: Global minimum test result. For patients with a satisfactory recovery.   
For example CaDP-min  and ICaDP-min represent the minimum plasma calcium and 
ionized calcium at the end of the drop phase.  On the other hand, CaG-min and ICaG-min are 
the global minimums.   
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 T-RG-min:  Time after surgery corresponding to RG-min  
 T-RDP-min: Time after surgery corresponding to RDP-min.  In many patients, presumably 
uncomplicated, T-CaG-min and T-CaDP-min are expected to be the same. 
Various characteristics of the patient’s recovery are analyzed.  Since several of them 
do not follow a normal distribution, non-parametric tests are performed to show the 
relationship among these features and the patient’s recovery.   
3.5 Identification of Postsurgical Complications Based on Test Results 
Research focusing in data driven models to support medical decisions has increased 
in the last years [39].   One of the aims of research in this field is to create enhanced 
patient profiles that consider available medical information to improve the decision 
making process.  However, the complex nature of laboratory test results, may lead to 
overlook patterns associated to patients who experienced postsurgical complications.  
This may happen because some of these patterns are undetectable to the naked eye, and to 
lack of robust techniques to conduct medical inference.  Thus it is important to 
investigate if additional valuable information can be extracted from the CBC and BMP 
components that will help to determine the likelihood of a patient suffering postsurgical 
complications. 
A CBC test is ordered to monitor disease progression, response to treatment or just as 
a routine checkup [5].  A CBC test helps physicians to start investigating causes of 
symptoms suffered by the patient, such as weakness, fatigue or pain [5].   Common 
identifiable conditions based on a CBC test are anemia, infections and leukemia [6]. 
Atypical variations on the CBC results may lead to further investigate the underlying 
medical condition that caused such symptoms. A CBC includes information about 
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hemoglobin (Hbg), white cell count (WBC), white cell differential count, red blood count 
(RBC), hematocrit (Hct), mean corpuscular volume (MCV), mean corpuscular 
hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), red cell 
distribution width (RDW), platelet count, and mean platelet volume (MPV) [4]. When 
ordering this test physicians are mostly interested in Hbg, WBC and RBC due to their 
known relationship with most common diseases [5, 6, 40].  Thus physicians use the test is 
to validate their hypothesis about the condition that the patient is suffering. Physicians 
working with the research team strongly argue that the concurrent analysis of other 
results could improve the assessment of the patient condition.  
Similarly, BMP test is commonly ordered to assess patient condition. BMP measures 
blood sugar levels, fluids balance, and kidney function [40], in terms of the levels of 
sodium, potassium, creatinine, total bilirubin, total protein, carbon dioxide, glucose, 
chloride, blood urea nitrogen (BUN) and calcium.  Blood sugar levels are measured in 
terms of glucose, which is the most important source of energy used by the human body.  
Fluids balance is measured in terms of electrolytes (potassium, calcium and sodium), 
needed to keep normal live functions, such as heart rhythm, muscle contraction, and brain 
function [6].  Health conditions associated to electrolytes unbalance are heart disease, 
muscle weakness, kidney disease, endocrine diseases, eating disorders, or bone disorders. 
There are conditions that affect fluids balance, such as diarrhea, vomiting, fever, or 
taking diuretics. Also, calcium levels are important for healthy bones and teeth, as well as 
for normal muscle and nerve function. 
It becomes necessary for physicians to enhance their ability to interpret laboratory test 
results, to timely identify changes in a patient’s condition, order accurate interventions 
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and make better patient care decisions. The fundamental goal is to improve the current 
use of laboratory results by demonstrating how to extract valuable information from 
existing clinical datasets.  
Laboratory tests are ordered by physicians as part of a discrete monitoring process of 
patient health evolution. As mentioned before, CBC and BMP are the most common tests 
ordered by physicians to assess kidney functions, electrolytes and blood cells count.  Ri 
denotes a series of l laboratory results {k=1, . . . ,l}, for a given patient i {i=1, . . . , n}, for 
a set of m tests {j=1, . . . ,m} can be represented as follows: 
   
 
 
 
 
 
 
         
         
    
         
         
   
         
   
         
         
   
          
 
 
 
 
 
                                               
In real practice, laboratory tests are ordered by the physicians without following a 
standard guideline about its periodicity.  Moreover, there are no methodologies available 
to determine an appropriate sampling rate for monitoring patients after undergoing 
cardiovascular surgery. This creates a non-uniformly sampled process and a problem if a 
physician wants to compare the recovery of two patients at the same time.   
For a given patient i and test j, the vector Rij represents the history of laboratory test 
results over time and        the k
th 
result, sampled at time t {t=t1, . . . ,tk}.   
                                       
Notice that the values of k denote the order in which the samples are taken. On the 
other hand, t represents the actual time when the sample was taken. Since we want to 
(3.1) 
(3.2) 
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analyze patients’ recovery cycle, time zero will be assumed as the time of surgery for 
each patient.   
For a non-uniformly sampled process, two patients may not have the same number of 
samples, and they may not be taken at the same intervals. Moreover, depending on the 
patient’s evolution, the length of stay will also vary among patients, increasing the 
numbers of samples.  Non-uniformly sampled data creates a challenge for various 
methods of analysis, such as time series, due to the need of converting these irregular 
observations to periodic observations [36]. To construct standardized datasets, the 
proponents will test the ability of several interpolation and modeling techniques to 
capture the changes in the components of CBC and BMP over time. Once the best 
technique is identified, the proponents will construct an equally time-spaced sequence of 
test results for every patient.   
Due to the trauma caused by the surgery, the loss of blood and the effort of the human 
body to keep normal functions, a major disturbance is created in the patients’ test results 
after surgery.  Two patterns are observed in test results immediately after surgery: 
positive and negative acute response to the surgery.  As the names suggest, a variable 
shows a negative/positive acute response when its levels drop/increase significantly after 
an event, in this case surgery. Physicians working with the research team have observed 
that the calcium level falls until it reaches an average level of 7.5 mg / Dl (reference 
range = [9, 10.5] mg/Dl), and then it begins to recover its normal levels after the second 
day of the postsurgical period.   The time to return back to the reference range could vary 
among patients, due to the differences in the recovery cycle.   
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3.6 Characterization of the Time Series  
Based on the aforementioned classification, an analysis of the differences of the 
patterns of the DP, RP, RDP-min, RG-min, T-RG-min, T-RDP-min for all patient types and 
laboratory tests will be performed.  This analysis will provide overall statistics about the 
patient population. Parametric and non-parametric tests, as well as correlation analysis 
were performed on the data to identify differences among patients’ laboratory test results 
and patterns among patients who had postsurgical complications. 
Current patient monitoring practices rely on the power of reference ranges in 
detecting abnormalities in test results.  Unfortunately, results are analyzed individually or 
at most comparing two or three tests at the same time.  Physicians do not have a proper 
way of including more results (variables) to make inferences about the patient’s 
condition. The proponents will identify the most relevant test results patterns associated 
to patients experiencing complications. Also, interpretation of suspicious patterns in test 
results will allow providers to improve current patient monitoring practices. The 
development of multi-test-based monitoring process will assist physicians to observe and 
understand interactions among test results and their relationship with patient’s health 
evolution.  
Healthcare information systems collect a great deal of data over time about patient 
evolution. As stated before, this data needs to be analyzed to provide physicians with 
useful information that enhance the diagnosis process.  The understanding of the patient 
evolution during the postsurgical period would help physicians to anticipate undesirable 
changes in the patient’s condition and prescribe treatment(s) more effectively.   For 
example, if two patients share the same result at some point in time, physicians cannot 
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assure that the patients are in the same stage of their evolution after surgery.  Certainly, 
physicians use additional data to assess patient condition (symptoms described by the 
patient, family history, demographics, etc.) but for patients with similar profile the 
evolution may vary significantly.   
Patient recovery patterns vary according to the patient’s health condition. Preliminary 
observations show that patients experiencing complications spend more time recovering 
normal levels (within the reference range) of platelets, calcium and mean platelet volume.  
The construction of a patients’ similarity matrix, will provide a metric of the differences 
among patients’ recovery.  
Since all the tests results are in different scales, a time series of their rate of change 
will be used to construct the patients’ similarity matrix.   Given two consecutive test 
results rt-a and rt at time t-a and t, the rate of change at time t for a given test,   , can be 
represented mathematically as follows:  
   
       
 
   
                            
Time series constructed based on the rate of change have different lengths due to the 
non-uniformly sampled nature of monitoring process.  Commonly used similarity 
measures, such as Euclidean distance, do not consider uneven time series. However, there 
are methods such as dynamic time warping (DTW) that allows the calculation of 
distances between time series with different length. DTW will be used to calculate 
similarity among the patients’ recovery. Let Qi and Qi’ be the rate of change time series 
of tests results of two different patients:                       and     
                        . The DTW algorithm will compare them by lining them up to 
(3.4) 
 
(3.3) 
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minimize their difference. As a result, the algorithm will provide a k x k’ distance matrix, 
Dij, where the Dij(t,t’) position represents the Euclidean distance between the t
th
 and the 
t’th element of the series Qi and Qi’ respectively for patient i and i’ , and test j. The 
calculation of the Dij matrix elements will be performed for all the components of the 
CBC and BMP for every patient.   
The minimum distance between these time series is the sum of the elements of the 
warping path W, where:  
                                                      
                        
The warping path W, is the minimum path from the position Dij(1,1) to Dij (k,k’). The 
minimum path will be determined using dynamic programming techniques.  The 
mathematical expression that represents the minimum distance between these time series 
is: 
      
     
   
 
   
 
         
This calculation will be performed for each pair of rate of change time series, for each 
pair of patients. As a result, m-matrices will be created for each patient, one for each 
analyzed test.  
The n x n matrix S, shows the patients’ similarity values, as follows: 
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where             
  
    . This matrix summarizes the metrics used for comparison 
between every two patients in the training set. 
Several clustering techniques are tested to identify which one offers better 
performance in clustering patients’ based on the matrix S. Also, the authors investigate 
what is the best number of clusters that better describe patient’s evolution. The main 
focus is fuzzy clustering techniques because they could provide more detailed 
information about the patient condition, by providing membership values for a patient 
into different clusters.  Other techniques are also tested. 
Fuzzy clustering techniques are used on this research to efficiently cluster patients 
according to their similarities during the postsurgical period.  It is expected that each one 
of the clusters will represent a specific patient recovery pattern. Let     represent the 
membership value of patient i in cluster v, where C is the total number of clusters. The 
algorithm intends to minimize the expression:   
   
    
  
   
         
      
   
   
  
    
 
    
Membership values should satisfy the following conditions:                   
      
 
        and,       
 
           . 
Next section shows an analysis of postsurgical plasma calcium, ionized calcium and 
platelet count based on their characterization as time series, as well as their relation 
during patients’ recovery phase.  
 
 
 
(3.9) 
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Chapter 4: Analysis of Postsurgical Plasma Calcium, Ionized Calcium and Platelet 
Count Test Results 
 
 
 
This chapter presents an analysis of different features of postsurgical plasma calcium. 
The main objectives are to characterize the behavior of postsurgical plasma calcium test 
results and to find key differences on the plasma calcium results over time for the 
different patient types.   
4.1 Plasma Calcium: Reference Ranges 
According to the USMLE [19] the reference range for plasma calcium is between 8.5 
and 10.5 mg/dl.  However, since the actual baseline data is available, reference ranges for 
the population of this study are developed. The test results used to construct the reference 
ranges are the last result before undergoing surgery.  Figure 4.1 shows the frequency 
distribution of the pre-surgical plasma calcium for the patient population included in the 
study.   The reference range for the population of this study is [8.68 - 10.55] mg/dl 
(μ=9.617; σ = 0.4675).  The frequency distributions found in the literature do not differ 
appreciably from the results obtained by constructing a reference range for plasma 
calcium for the population of this study (reference ranges are constructed based on the 
mean of the results from a healthy population ± 2 standard deviations).    
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Although, the plasma calcium frequency distribution shows a fairly Gaussian shape, 
the hypothesis of normality was rejected after performing a Kolmogorov-Smirnov test (p-
value=0.034); probably due to presence of some outliers that create a heavy tailed 
frequency distribution. Yet a statistical test without the outliers yielded the same results 
although with a more symmetrical distribution. Although small subgroups (types 3 and 4) 
were not different by Wilcoxon test, we will assume that the parent distribution is not 
normal and will employ non-parametric statistical methods where applicable. 
 
Figure 4.1 Frequency distribution of pre-surgical plasma calcium of the study population 
 
 
To confirm that there were not baseline differences in the subsequently identified 
patient groups, the four groups were compared by a Kruskal-Wallis test, which showed 
no baseline difference. This was further analyzed by applying individual Wilcoxon tests 
between pairs of groups as a ―post-hoc‖ test, and again there was no consistent difference 
between baseline groups. A summary of the results is presented in table 4.1 and 4.2. 
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Population Type 1 Type 2 Type 3 Type 4
Mean 9.617 9.685 9.550 9.794 9.520
Standard Deviation 0.467 0.467 0.462 0.410 0.427
Patient Type P-Values
Type 1 - Type 2 0.010
Type 1 - Type 3 0.545
Type 1 - Type 4 0.432
Type 2 - Type 3 0.210
Type 2 - Type 4 0.901
Type 3 - Type 4 0.347
Table 4.1 Mean and standard deviation of pre-surgical plasma calcium (mg/dl) 
   
 
 
Table 4.2 p-values from a two-sample Wilcoxon rank sum test for pre-surgical plasma calcium 
 
 
 
 
It is also noted that although the p-value obtained by comparing pre-surgical plasma 
calcium for patient types 1 and 2 is equal to 0.01, the difference in the means is not 
significant from the medical perspective, since these values are close to the central point 
of the reference range.  In summary the pre-surgical plasma calcium results do not 
provide enough information to assess how likely the patient is to have, or not, 
postsurgical complications. 
4.2 Plasma Calcium: Initial and Global Minimums  
A decrease in plasma calcium levels was initially described in a study of patients with 
pancreatitis; where it was found that low calcium is an indicator of a severe disease [20].  
Also a decrease in plasma calcium has been reported in patients with sepsis [21].  In their 
long medical and healthcare practice two of the committee members, Drs. Fabri and 
Foulis, they have observed that a drop in the plasma calcium after cardiovascular surgery 
is expected as a negative acute response to the surgery. 
 In this study, the plasma calcium drops below the lower bound of the reference range 
for the majority of the patients reaching its minimum value CaDP-min, on average, during 
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the second day after surgery. Once CaDP-min is reached, the plasma calcium begins to 
return towards a normal level for patients who had a satisfactory recovery, while for 
patients experiencing complications the plasma calcium does not show a stable increasing 
trend.   For patients experiencing complications, the plasma calcium shows an initial 
increase towards normal levels, and then it shows a non-stable trend. In some cases, these 
variations make the plasma calcium results to drop even below the CaDP-min.   
This global minimum, CaG-min, is expected to be the same as CaDP-min, for patient’s 
type 1 and 4.  For patients’ type 4, who died without experiencing any increase after the 
initial minimum, the minimum plasma calcium is taken from the last test prior to death.  
Table 4.3 presents a summary of the average values for CaDP-min and CaG-min. 
Table 4.3 Mean and standard deviation for CaDP-min and CaG-min (mg/dl) 
 
The values of CaG-min for patients type 3 and 4 are lower than for patients type 1 and 
2.  These values represent values reported prior to death for the majority of the patients, 
and differ significantly from the CaDP-min.  Figure 4.2 and 4.3 show the frequency 
distribution of CaG-min and CaDP-min respectively.   
Both frequency distributions show a Gaussian shape, but the normality assumption 
was also rejected (pvalue=0.04).  A two-sample Wilcoxon rank sum test was performed 
to determine if there is a significant difference between the CaG-min and CaDP-min for all 
patient types (table 4.4).  
Population Type 1 Type 2 Type 3 Type 4
Mean 7.608 7.646 7.582 7.540 7.380
Standard Deviation 0.587 0.598 0.579 0.416 0.726
Mean 7.549 7.608 7.513 7.100 7.380
Standard Deviation 0.545 0.557 0.525 0.424 0.726
Ca DP-min 
Ca G-min 
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Figure 4.2 Frequency distribution of CaG-min  
 
 
 
 
Figure 4.3 Frequency distribution of CaDP-min 
 
 The test results showed no significant difference in the values of minimum values of 
CaG-min and CaDP-min.  This implies that a single value of plasma calcium is not enough to 
establish whether a patient is suffering complications or not.  However, a single markedly 
decreased level is suggestive of complications, which may signify that temporal analysis 
of calcium levels could provide more information. 
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Table 4.4 p-values from a two-sample Wilcoxon rank sum test of CaG-min and CaDP-min  
 
4.3 Plasma Calcium: T-CaG-min and T-CaDP-min 
The time to reach the CaDP-min (T-CaDP-min), could be an important predictor of the 
appearance of complications after surgery.  Small values of T-CaDP-min can be caused by 
the steepness on the drop of plasma calcium, whereas larger values could indicate a 
smaller effect of the surgery on the level of plasma calcium for those patients.  The T-
CaG-min should differ among patient’s groups due to the late appearance of complications 
for patients’ type 2 and 3 during the recovery phase.  It is expected that T-CaG-min for 
these patients will be considerably larger than their T-CaDP-min. Table 4.5, figure 4.4 and 
figure 4.5 and show the behavior of T-CaDP-min and T-CaG-min . 
Table 4.5 Mean and standard deviation for T-CaDP-min and T-CaG-min 
 
 
 
Patient Type Ca G-min  Ca DP-min
Type 1 - Type 2 0.372 0.156
Type 1 - Type 3 0.844 0.053
Type 1 - Type 4 0.204 0.236
Type 2 - Type 3 0.881 0.094
Type 2 - Type 4 0.277 0.349
Type 3 - Type 4 0.396 0.750
p-values
Population Type 1 Type 2 Type 3 Type 4
Mean 1.120 1.033 1.215 0.952 0.880
Standard Deviation 0.529 0.472 0.574 0.209 0.396
Mean 1.774 1.296 2.122 5.729 0.880
Standard Deviation 2.013 1.095 2.353 4.807 0.396
T-Ca DP-min 
T-Ca G-min 
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Figure 4.4 Frequency distribution of T-CaG-min  
 
Figure 4.5 Frequency distribution of T-CaDP-min 
 
The mean values for T-CaDP-min show that the end of the drop phase occurs, on 
average, at the beginning of the second day.  The means among patient groups differ just 
by a few hours, indicating that there is not a marked difference in the values of T-CaDP-
min.  However, the values of T-CaG-min show a considerable difference among them.  For 
patients who experienced complications and died, the value of T-CaG-min is, on average, 
5.729 days, while for patients who had a satisfactory recovery T-CaG-min is 1.296 days.  A 
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two-sample Wilcoxon rank sum test was performed to test the differences among the T-
CaDP-min for all patient types. The same analysis was carried out for T-CaG-min.   Results 
are summarized in table 4.6.   
Table 4.6 p-values from a two-sample Wilcoxon rank sum test of T-CaG-min and T-CaDP-min  
 
  
In general there is not a significant difference in the value of T-CaDP-min among 
patients, indicating that all the patients experience the same drop in plasma calcium after 
cardiovascular surgery.  However, there is a significant difference in the values of T-CaG-
min among patients who experienced complications, type 2 and 3, and patients who did 
not.  Patients who experienced complications have larger variability than type 1 patients 
during the recovery process.  For patients experiencing complications, the plasma 
calcium drops even below the CaDP-min.. 
The analysis of the variation of plasma calcium provides valuable information to 
assess patient condition.  Physicians can monitor the plasma calcium based on its 
variation over time, having as reference the lowest level and the instance when it 
occurred.  A negative trend of plasma calcium should trigger an alarm, indicating that 
there is a risk of dropping to levels close to the CaDP-min.  The next section presents an 
Patient Type T-Ca G-min  T-Ca DP-min
Type 1 - Type 2 0.002 0.007
Type 1 - Type 3 0.044 0.853
Type 1 - Type 4 0.313 0.384
Type 2 - Type 3 0.117 0.360
Type 2 - Type 4 0.088 0.133
Type 3 - Type 4 0.095 0.296
p-values
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analysis of the variation of plasma calcium over time.  This analysis is based on plasma 
calcium slopes during the drop and recovery phase. 
4.4 Plasma Calcium Slopes during the Drop and Recovery Phase  
The analysis of the variation of plasma calcium could help in the timely identification 
of postsurgical complications.  It is necessary to analyze the temporal variation of 
calcium to determine what information can be extracted. 
The temporal variation of plasma calcium is analyzed in terms of the slope during the 
drop and recovery phase.   Table 4.7 shows the mean and standard deviation of the 
plasma calcium slopes during the drop and recovery phase for the population of this 
study.  A two-sample Wilcoxon rank sum test was performed to test the difference of the 
plasma calcium slope during the drop and recovery phase for all patient types. 
Table 4.7 Plasma calcium slopes during the drop and recovery phase  
 
As it was shown in the previous section, the behavior of the plasma calcium (slope) 
during the drop phase is the same for all patients.  However, there is a significant 
difference in the values of slope during the recovery phase (table 4.8).  Notice that the 
Slope Drop Phase Slope T-Ca DP-min - 7th Day
Mean -2.288 0.178
Std. Dev. 1.340 0.195
Mean -2.415 0.207
Std. Dev. 1.291 0.188
Mean -2.144 0.158
Std. Dev. 1.389 0.196
Mean -2.523 -0.033
Std. Dev. 0.783 0.182
Mean -2.784 -
Std. Dev. 1.433 -
Type 4
Type 3
Type 2
Type 1
Population
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comparisons were made between type 1, 2 and 3, since type 4 patients died during the 
drop phase. 
Table 4.8 p-values from a two-sample Wilcoxon rank sum test of the plasma calcium 
slope during the drop and recovery phase for all patient types
 
The recovery pattern of plasma calcium, following the initial minimum, appears to be 
a useful indicator for assessing patient recovery.  Since there is not a marked difference 
among patients during the drop phase, differences in patient condition start to be 
recognized after the plasma calcium reaches the CaDP-min.  Variations on the ascending 
trend of plasma calcium during the recovery phase should be an indicator of an 
unrecognized complication on patient condition. This is even more critical if the test 
results are close to the lower bound of the reference range or to the CaDP-min.   
However, it could be argued that variations in plasma calcium are due to the 
variations on plasma albumin, as it is commonly assumed.  The next section presents an 
analysis of the relationship of the variations on plasma calcium and ionized calcium. 
4.5 Analysis of Ionized Calcium Results 
The main objective of analyzing postsurgical ionized calcium, and its relationship 
with variations in plasma calcium, is to demonstrate that variations in plasma calcium are 
not principally due to a change in plasma albumin, but rather a proportional decrease in 
Patient Type Slope Drop Phase Slope T-Ca DP-min - 7th Day
Type 1 - Type 2 0.0577 0.017
Type 1 - Type 3 0.6789 0.0105
Type 1 - Type 4 0.5452 -
Type 2 - Type 3 0.2825 0.044
Type 2 - Type 4 0.2482 -
Type 3 - Type 4 0.8345 -
p-values
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ionized calcium.  Since the ionized calcium is mostly sampled during the perioperative 
period, the analysis that is presented in next sections is based on its variations during the 
drop phase, which is when the major changes in plasma calcium occur  
4.5.1 Ionized Calcium: Reference Ranges 
On average, the pre-surgical ionized calcium is 1.169 mmol/L, which falls within the 
reference range which is [1.1, 1.4] mmol/L [22].  An ionized calcium reference range for 
the population of this study was developed based on the last result before undergoing 
surgery.  The developed reference range is [0.955, 1.382] mmol/L (μ = 1.169; σ = 0.107).   
The upper bounds of the reference ranges found in the literature do not differ 
significantly from the results obtained by constructing this reference range for ionized 
calcium (mean + 2σ), but the lower bound is considered low for this population.  
Approximately, 16% of the patients have levels of ionized calcium below the lower 
bound of the reference range prior to surgery.  Figure 4.6 shows the frequency 
distribution of the pre-surgical ionized calcium. 
 
Figure 4.6 Frequency distribution of pre-surgical ionized calcium of the study population 
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The pre-surgical ionized calcium for all the patient types appears to be similar.   Table 
4.9 shows the mean and standard deviation of pre-surgical ionized calcium by patient 
type.  Since the assumption of normality was rejected (p-value =0.018), a Kruskal-Wallis 
non-parametric ANOVA test was performed to test whether there is a difference among 
pre-surgical ionized calcium.   It was found that there is not enough evidence to reject the 
null hypothesis, thus there is no difference in the pre-surgical ionized calcium results 
among patients (p-value = 0.982; Adjusted for ties p-value = 0.852). 
Table 4.9 Mean and standard deviation for pre-surgical ionized calcium (mmol/L) 
 
As it was found for plasma calcium, the pre-surgical ionized calcium results do not 
correlate with the presence of postsurgical complications.   
4.5.2 Analysis of Ionized Calcium’s Drop Phase 
During the drop phase, patients experienced a drop in the ionized calcium.  On 
average, the ionized calcium drops until it reaches 0.936 mmol/L (σ = 0.089) and then 
starts to return back to normal.  This minimum is reached, for almost 95% of the patients, 
within the first 24 hours after surgery (µ = 0.5463 days; σ = 0.2637 days).  Commonly, 
during cardiovascular surgery, patients receive free calcium intravenously, but not post-
operatively.    
When intravenous calcium gluconate is administered, the rise in ionized calcium is 
small and of very short duration, with the ionized calcium quickly returning to the 
previously depressed levels.    
Population Type 1 Type 2 Type 3 Type 4
Mean 1.169 1.171 1.168 1.098 1.196
Standard Deviation 0.107 0.106 0.109 0.097 0.040
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Table 4.10 summarizes the values of T-ICDP-min and ICaDP-min for the patients included 
in the study.  These data suggest that the ionized calcium regulatory system may be 
―reset‖ resulting in a decrease in both ionized and total calcium. 
Table 4.10 Mean and standard deviation for ionized calcium T-ICaDP-min and  ICaDP-min . 
 
On average, the value of ICaDP-min is considerably lower for patients who died after 
surgery.  A Kruskal-Wallis non-parametric ANOVA test was conducted to test if there is 
a significant difference in the values of ICaDP-min among patient types. The resulting p-
value was 0.779 (adjusted for ties p-value = 0.295), therefore, the null hypothesis is 
accepted and it can be claimed that there is no statistical difference in the values of ICaDP-
min  among patient types.   
The same procedure was carried out for ionized calcium’s T-ICaDP-min.  As a result, it 
was found that there is not a significant difference in the values of T-ICaDP-min (p-value = 
0.990, adjusted for ties p-value = 0.395) among patient types.  Although, there is not 
sufficient statistically evidence to claim that there is a difference in the values of T-CaDP-
min and ICaDP-min for the patients included in the study, a slight difference is noticed in the 
mean values of T-ICaDP-min and ICaDP-min.  For T-ICaDP-min the values are higher for 
patients experiencing complications, whereas for ICaDP-min occurs the opposite.    
The ionized slope during the drop phase could be an indicator of the effect of the 
surgery on the patients.  Table 4.11 summarizes the ionized calcium slope during the drop 
phase for all patient types. 
Population Type 1 Type 2 Type 3 Type 4
Mean 0.941 0.951 0.937 0.872 0.866
Standard Deviation 0.089 0.086 0.089 0.068 0.136
Mean 0.574 0.555 0.588 0.602 0.695
Standard Deviation 0.237 0.211 0.255 0.149 0.429
ICa DP-min 
T DP-min 
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Population Type 1 Type 2 Type 3 Type 4
Mean -0.999 -1.005 -0.976 -1.187 -1.359
Standard Deviation 1.425 1.150 1.668 1.168 0.774
Table 4.11 Ionized calcium slope during the drop phase for all patient types 
 
 
 
After performing a Kruskal-Wallis non-parametric ANOVA test on the data, it was 
found that there is not a significant difference in the values of the slopes of ionized 
calcium during the drop phase  (p-value = 0.999; adjusted for ties p-value = 0.489) among 
patient types.  However, it can be noticed that the steepness on the drop of ionized 
calcium for patients who died during the perioperative period is higher.  
Although, there is not enough statistical evidence, there are some hints that can help 
in assessing patient condition.  High negative slopes can be the consequence of the direct 
effect of the operation.  Notice that the same conclusions were drawn for plasma calcium 
during the drop phase. 
4.5.3 Cross Correlation Analysis between Plasma and Ionized Calcium  
It is observed that postsurgical plasma and ionized calcium show a similar behavior 
over time. Both present a noticeable drop during the perioperative period and then start to 
return back to normal.  A cross correlation analysis is performed to test the relationship 
between the time series of plasma and ionized calcium results.  The time series created 
for this purpose are based on 12 hour-intervals.  Figure 4.7, shows the frequency 
distribution of correlation between postsurgical plasma and ionized calcium.  
On average, the correlation between both time series is 0.41 across the patient 
population without performing any shifting on the time series (lag = 0).   This average is 
highly influenced by the heavy tail to the left on the frequency distribution.   In general, a 
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large portion of the population (70%) shows a correlation greater than 40% between both 
time series, indicating that both time series behave approximately the same during the 
postsurgical period. 
Figure 4.7 Frequency of correlations between postsurgical plasma and ionized calcium 
 
For 19% of the patients on the study there is a negative correlation between plasma 
and ionized calcium.  This may be due to the administration of medications containing 
calcium.  It is expected that if this effect is blocked the correlation will increase 
positively.  Unfortunately, there are a series of factors, such as the effect of treatments, 
diet, metabolism and comorbidities, that affect the behavior of postsurgical laboratory 
test results. This reality makes difficult the identification of possible sources of variability 
in laboratory tests since we do not have access to other possible contributing factors 
4.6 Platelet Count: Reference Ranges 
According to the USMLE [19] the reference range for platelet count is from 150,000 
to 450,000 per milliliter.   Just as it was calculated for plasma calcium, reference ranges 
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for the population of this study are developed based on test results. Initially, the last result 
before undergoing surgery was extracted from the dataset for each patient.  Figure 4.8 
shows the frequency distribution of the pre-surgical platelet count. 
 
Figure 4.8 Frequency distribution of pre-surgical platelet count of the studied population 
 
The reference range for the population of this study is [99,270 – 359,362] platelets 
per milliliter (μ = 229,320; σ=65,021).  The frequency distributions found in the literature 
differ appreciably from the results obtained by constructing this reference range for 
platelet count (mean ± 2σ).   Although, the platelet count frequency distribution shows a 
fairly Gaussian shape, the hypothesis of normality was rejected after performing a 
Kolmogorov-Smirnov test (where the test statistic was equal to 0.0658 and the 
corresponding p-value was equal to 0.0607), due to presence of some outliers that create 
a heavy tailed frequency distribution.  
Even though the normality assumption was rejected, it is possible that, if the number 
of samples increases, the data could be modeled as a normal.  Still it is important to 
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determine whether baseline differences among the different type of patients are 
significant. Results from the four groups were compared using a Kruskal-Wallis test and 
further analyzed by applying individual Wilcoxon tests between pairs of groups as a 
―post-hoc‖ test, just as it was done for plasma calcium.  A summary of the results is 
presented in table 4.12 and 4.13. 
Table 4.12 Mean and standard deviation for pre-surgical platelet count (mg/dl) 
   
Table 4.13 p-values from a two-sample Wilcoxon rank sum test for pre-surgical platelet count  
 
The results from the two-sample Wilcoxon rank sum test showed that there are not 
significant differences between the pre-surgical platelet count among patient types. 
However, it is noticeable that the lowers p-values correspond to the comparison between 
patient groups 1 and 4, and 2 and 4, which are the most dissimilar types of patients, since 
patients type 1 and 2 survived and patient type 4 died during the perioperative period.  
Also, the higher p-values are associated to the comparison between patient type 2 and 3, 
and 3 and 4.  In the first case, the relation may be caused by the fact that these 2 patient 
populations had complications during the postsurgical period and in the second case 
because they both died.   
Population Type 1 Type 2 Type 3 Type 4
Mean 229.32 234.15 226.89 203.60 191.20
Standard Deviation 65.02 62.92 66.66 76.66 60.21
Patient Type P-Values
Type 1 - Type 2 0.325
Type 1 - Type 3 0.458
Type 1 - Type 4 0.152
Type 2 - Type 3 0.629
Type 2 - Type 4 0.245
Type 3 - Type 4 0.676
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As a conclusion, the pre-surgical platelet count does not provide enough statistical 
confidence to associate it to the likelihood of postsurgical complications.  However, an 
expected difference is observed on the mean of the patient groups where the pre-surgical 
platelet count is lower for patients who had complications or died.  
4.7 Platelet Count: Initial and Global Minimums  
A decrease in platelet is anticipated for patients who underwent cardiovascular 
surgery due to their consumption during the wound healing.  In this study, platelet count 
levels drop below the lower bound of the reference range for the majority of the patients.  
As it was defined for plasma calcium, PDP-min represents the platelet count level when the 
initial minimum is reached.  For plasma calcium this value is reached, in average, during 
the second day after surgery, day where the CaDP-min occurs.  This event shows that both 
test results fall dramatically during the first day after surgery, reaching their minimum at 
the second day, which becomes a critical day for the patient care.  For patients with a 
satisfactory recovery process, once the minimum is reached, the platelet count goes back 
to values within the reference range.   Results from patients who experienced 
complications do not show this behavior; for them, the platelet count drops again, to 
levels even lower level than the initial.   As it was assumed for plasma calcium, PG-min is 
expected to be the same as PDP-min, for patient’s type 1 and 4.  Table 4.14 presents a 
summary of the average values for PDP-min and PG-min.   
Table 4.14 Mean and standard deviation for PDP-min and PG-min for all patient types (mg/dl) 
 
Population Type 1 Type 2 Type 3 Type 4
Mean 132.09 134.07 130.17 69.60 135.20
Standard Deviation 56.28 55.57 50.94 20.21 56.89
Mean 122.09 125.50 119.27 55.40 124.20
Standard Deviation 50.24 47.55 47.12 24.93 61.28
P DP-min 
P G-min 
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The mean value of PG-min for patients’ type 3 is the lowest.  These values are mostly 
captured prior to the patient’s death.  These results differ significantly from the other 
patients’ types.  It is noticeable that for patient type 1, 2 and 4, PG-min is about the same 
even when their recovery process and outcome differ.  Since patients type 4 died during 
the perioperative period, it is possible that their platelet count levels did not have time to 
show a large decrease, since the main consumption of platelets occurs during the 
recovery phase (when the complications during the wound healing process appear most 
frequently).  .  Figures 4.9 and 4.10 show the frequency distribution of PG-min and PDP-min 
respectively.   
Both frequency distributions show a skewed Gaussian shape, which results in the 
normality assumption not holding in this case. To test whether there is a significant 
difference between PG-min and PDP-min for all patient types, a two-sample Wilcoxon rank 
sum test was performed.  Results are shown in table 4.15. 
                             
Figure 4.9 Frequency distribution of PG-min 
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Figure 4.10 Frequency distribution of PDP-min  
 
The test results showed no significant difference in the values of minimum values of 
PG-min and PDP-min, for patient type 1, 2 and 4.   This implies that for these patient types, 
the PDP-min corresponds to their PG-min in the majority of the cases.  Based on these results, 
the platelet count level for patients’ type 2 is not expected to drop below their PDP-min 
after the drop phase, if it drops below PDP-min it is a clear symptom of the severity of the 
complication.  PG-min and PDP-min results from patients’ type 3 are significantly different 
from the results from other patient types.    
Table 4.15 p-values from a two-sample Wilcoxon rank sum test of PG-min and PDP-min  
 
0
10
20
30
40
50
60
F
re
q
u
en
cy
Platelet Count (x 1000) per mm3
Patient Type P G-min  P DP-min
Type 1 - Type 2 0.3191 0.7589
Type 1 - Type 3 0.0009 0.0028
Type 1 - Type 4 0.91 0.8422
Type 2 - Type 3 0.0018 0.004
Type 2 - Type 4 0.9748 0.8536
Type 3 - Type 4 0.0758 0.0758
p-values
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A single value of platelet count does not provide enough information to establish 
whether a patient is suffering complications or not, since there is not a significant 
difference between the results of patient type 1 and 2.  However, for patients’ type 3 it 
can be noticeable lower values of PG-min and PDP-min that for others, a single markedly 
decreased level after the drop phase it can be interpreted as a sign of possible 
complications on the patient recovery.  Also, this suggests that a temporal analysis of 
platelet count should be performed to confirm the appearance of complications.  
4.8 Platelet Count: T-PG-min and T-PDP-min 
The time to reach the PDP-min (T-PDP-min), is an important indicator to consider since 
small values represent a rapid drop of platelet count caused by internal bleeding.  Also, 
large values could indicate that patient platelet production is enough to successfully heal 
the wounds after surgery, indicating a mild effect of the surgery on its levels.  As it was 
stated for plasma calcium, the T-PG-min should differ among patient’s groups due to the 
late appearance of complications for patients’ type 2 and 3 during the recovery phase.  It 
is expected that T-PG-min for these patients will be considerably larger than their T-PDP-min.   
Figure 4.11, 4.12 and table 4.16 show the behavior of T-PDP-min and T-PG-min for the 
population of this study.  
Table 4.16 Mean and standard deviation for T-PDP-min and T-PG-min  
 
 
 
Population Type 1 Type 2 Type 3 Type 4
Mean 2.162 2.113 2.198 3.177 0.942
Standard Deviation 1.295 1.154 1.367 1.563 0.803
Mean 4.205 3.823 4.406 4.119 1.029
Standard Deviation 5.790 4.958 6.346 1.673 0.350
T-P DP-min 
T-P G-min 
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Figure 4.11 Frequency distribution of T-PG-min  
 
 
Figure 4.12 Frequency distribution of T-PDP-min 
 
The mean value for T-PDP-min shows that the end of the drop phase occurs, on average, 
at the beginning of the second day, just as it was found for plasma calcium.  However, the 
means among patient groups differ, in the case of patient type 1 and 2 just by a few hours, 
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Patient Type T-P G-min  T-P DP-min
Type 1 - Type 2 0.5883 0.6388
Type 1 - Type 3 0.4013 0.1361
Type 1 - Type 4 0.6945 0.0282
Type 2 - Type 3 0.4323 0.1458
Type 2 - Type 4 0.8371 0.0419
Type 3 - Type 4 0.754 0.0367
p-values
indicating that there is not a marked difference in the values of T-PDP-min for these patient 
groups.  On the other hand, for patients on group 3 the minimum occurred on average at 
the beginning of the third day.  
 The values of T-PG-min show a considerable difference among patient groups.  For 
patients who experienced complications, the value of T-PG-min occurred at the fourth day 
after surgery, while for patients’ type 1 at the third.  A two-sample Wilcoxon rank sum 
test was performed to test the differences among the values of T-PDP-min for all patient 
types. The same analysis was carried out for T-PG-min.   Results are summarized in table 
4.17. 
Table 4.17 p-values from a two-sample Wilcoxon rank sum test of T-PG-min and T-PDP-min  
 
 
 
In general there is not a significant difference in the value of T-PG-min among patient 
groups, indicating that all the patients experience a similar drop in platelet count after 
cardiovascular surgery. This event also indicates that platelet count results are more 
variable than plasma calcium overtime after the drop phase.   However, there is a 
significant difference in the values of T-PDP-min among patients who died during the 
perioperative period and the rest of them.  This is an indicator that the platelet count 
drops dramatically for these patients.  This drop may be caused for complications during 
the surgery associated with internal bleeding.    
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The analysis of the variation of platelet count over time gives important information 
to assess patient condition.  Physicians can monitor the plasma calcium based on its 
variation, having as reference the lowest level and the instance when it occurred. Just as it 
was found for plasma calcium, a negative trend should trigger an alarm, indicating that 
there is a risk of dropping to levels close to the PDP-min.  As it was shown in table 4.15, the 
decreasing trend in platelet count results should end by the third day if the recovery 
process is satisfactory.  The next section presents a deeper analysis of the variation of 
platelet count over time, but focusing on tits slope during the drop and recovery phase. 
4.9 Platelet Count Slopes during the Drop and Recovery Phases  
The analysis of the variation of platelet count could help in the timely identification 
of postsurgical complications associated with bleeding and coagulation problems.  The 
analysis will be based on the construction of a data set with the platelet count slopes 
during the drop and recovery phase.   Table 4.18 shows the mean and standard deviation 
of the platelet count during the drop and recovery phase for the population of this study.   
Table 4.18 Platelet count slopes during the drop and recovery phase for all patient types 
 
Slope Drop Phase Slope T-P DP-min - 7th Day
Mean -16.728 0.037
Std. Dev. 29.620 0.078
Mean -17.417 0.043
Std. Dev. 27.194 0.072
Mean -13.559 0.036
Std. Dev. 20.394 0.085
Mean -17.027 0.015
Std. Dev. 7.246 0.032
Mean -71.689 -
Std. Dev. 113.193 -
Population
Type 1
Type 2
Type 3
Type 4
 58 
 
As shown in table 4.18, platelet count results have a negative slope for all patient 
types during the drop phase. This behavior shows that there is a decrease in platelet count 
for all patient types, but for patients’ type 4 it is steeper.  As it was assumed before, this 
behavior may be due to the presence of a massive loss of blood. 
A two-sample Wilcoxon rank sum test was performed to test the difference of the 
platelet count slope during the drop and recovery phase for all patient types.   The results 
from this analysis are shown in table 4.19.   
Table 4.19 p-values from a two-sample Wilcoxon rank sum test of the plasma calcium 
slope during the drop and recovery phase for all patient types 
 
The behavior of the platelet count (slope) during the drop phase is the same for all 
patients, as it was confirmed for plasma calcium. However, although there is not a 
significant difference in the values of slope during the recovery phase, it can be 
noticeable that the p-values are lower when results from the comparison between patients 
type 1 and 3, and 2 and 3; indicating that the slope for patients type 3 is steeper. Notice 
that the comparisons were made between type 1, 2 and 3, since type 4 patients died 
before this phase. 
The recovery pattern of platelet count, following the initial minimum, appears to be a 
useful indicator for assessing patient recovery.  Since there is not a marked difference 
Patient Type Slope Drop Phase Slope T DP-min - 7th Day
Type 1 - Type 2 0.9611 0.6543
Type 1 - Type 3 0.4714 0.2159
Type 1 - Type 4 0.9391 -
Type 2 - Type 3 0.5685 0.3366
Type 2 - Type 4 0.8887 -
Type 3 - Type 4 0.8345
p-values
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among patients during the drop phase, differences in patient condition start to be 
recognized after the platelet count reaches the PDP-min.  If the test results do not show the 
expected ascending trend during the recovery phase, it can be assumed as an indicator of 
an unrecognized complication on patient condition. This is even more critical if the test 
results are close to the lower bound of the reference range or to the PDP-min.  For almost 
all the patients the value of PDP-min was below the lower bound of the reference range, 
validating the usefulness of this benchmark. 
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Chapter 5: Time Series Clustering of Laboratory Test Results 
 
 
 
This chapter describes the performance of the proposed methodology for the analysis 
of laboratory test results, as well as the description of the procedure for the construction 
of the time series of laboratory test results and then, the patient clustering analyses as 
well as considerations for practical use of the methodology are shown.   
5.1 Construction of Datasets of Laboratory Test Results 
Based on the results from the previous chapter, it is noticeable the direct relationship 
between the results of plasma calcium and ionized calcium.  Due to the high correlation 
between plasma calcium and ionized calcium, ionized calcium is not included in the 
multivariate clustering analysis.  Consequently the multivariate clustering analysis is 
based on plasma calcium and platelet count test results over time 
For both tests, 8 different time series were constructed, based on data transformations 
and data manipulation to avoid missing data.  Since the data was not uniformly sampled, 
it was not possible to perform a time series analysis with the data as is;   it was necessary 
to perform mathematical transformations on the data to have equally time-spaced 
observation.  To achieve this goal, three interpolation methods were applied on the data, 
namely linear interpolation, polynomial interpolation and splines. Linear interpolation 
provided the best fit in modeling the trends on the data set for both tests.  When 
polynomial and splines were used, the estimation have more than n -1 degrees of 
freedom, which resulted in curves that were not similar to the tendencies observed on the 
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laboratory test results overtime.  The use of linear interpolation allowed a more accurate 
estimation of ―missing values‖. Based on the results after the implementation of linear 
interpolation, the estimation of results was performed at equally-spaced points in time. A 
detailed description of the methodology for the construction of these 8 time series is 
presented below.  For all datasets, the first value on this time series is the one associated 
to the last result before surgery (baseline).  
 Linear Interpolation:  The first data set was constructed using linear interpolation to 
estimate the test results every 12 hours.  The first value on this time series is the one 
associated to the last result before surgery (baseline), and then the sequence of 
estimations every 12 hours, based on the previous and the subsequent result in the 
dataset at this points in time.  
 Linear Interpolation (12 Hours):  This dataset differs from the previous.  To construct 
this dataset, a linear model was determined for to represent the behavior of the test 
results in 12 hours intervals.  Then, the model was used to estimate the results every 
12 hours.   
 Linear Interpolation (24 Hours): This dataset differs from the previous one just in the 
fact that the linear model was determined for to represent the behavior of the test 
results in 24 hours intervals.  Then, the model was used to estimate the results every 
24 hours.  
 Rate of Change: Based on the results from the first dataset (Linear Interpolation), a 
new dataset with the rate of change of results were constructed using equations 3.3 
and 3.4.  
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 Rate of Change (12 Hours): Same as previous dataset but using as a reference the 
Linear Interpolation (12 Hours) dataset.  
 Rate of Change (24 Hours): Same as previous dataset but using as a reference the 
Linear Interpolation (24 Hours) dataset. 
 Time Intervals:  Based on the experience of physicians in the committee, they stated 
that it is expected that at the third day after surgery the patient should leave the ICU.  
Then, at the sixth day it is expected that the patient is ready to perform routine tests to 
authorize the discharge by the seventh day. If the patient stays longer than 7 days, this 
may be an indicator of some complications or a slow recovery.  Then it seemed 
appropriate to construct a dataset estimating results every 3 days.  So, this time series 
starts with the baseline value, and then a linear model was determined for to represent 
the behavior of the test results in 3 hours intervals, from 0 to the 3
rd
 day after surgery, 
from the 3
rd
 day to the 6
th
, and from the 9
th
 to the 12
th
.   Patients that stayed longer 
than 12 days are considered as patients who experienced complications.  
 Segments: In the previous chapter, some features of laboratory test results were 
identified.  One of them is TDP-min , which will be used as a reference to create this 
dataset.  Once again, a linear model was created with the data points within the day of 
surgery and the TDP-min. Then, a model between TDP-min and time where the results go 
back within the reference range.  Then the procedure is the same as it was shown for 
the Time Intervals dataset.  
Several time series clustering techniques were applied to all the constructed datasets 
such as fuzzy logic based C-Means, Hierarchical and K-Means. Since for this setting it is 
difficult to draw hard partition conclusions, regarding the potential risk of complications, 
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fuzzy logic techniques are used to model the recovery process of patients after 
cardiovascular surgery.  The next section describes the results after the implementation of 
the proposed methodology. 
5.2 Multivariate Time Series Clustering 
 The implementation of multivariate time series clustering techniques provides a 
representation of the potential risks that patients suffer during their stay in the SICUs.  By 
calculating these membership values, and then segmenting them by patient group, patient 
risk profiles can be generated.  If the constructed clusters allow the identification of 
recovery patterns for the patient types defined before, then timely interventions can be 
performed for patients that are expected to have complications.   
Results from the implementation of multivariate clustering techniques are 
summarized in tables 5.1, 5.2 and 5.3.  Table 5.1 shows the membership values obtained 
after the implementation of fuzzy logic clustering, table 5.2 fuzzy C-Means and 5.3 fuzzy 
K-Means. 
Fuzzy clustering does not yield ―perfectly‖ classify patients according to their 
outcomes, maybe due to the similarities of the time series during the drop phase among 
patient types.  On the other hand linear interpolation classified all patients that suffered 
complications in the same cluster. However, it classifies on the same cluster around half 
of patients’ type 1 and 2, showing that this data set is not able to fully capture signs of 
possible complications that might his death.  The same situation is observed if the time 
intervals and the segments based datasets are used.  Also, around half of the patients who 
survived after surgery are classified on the cluster 1, where almost all the patients who 
died were classified.   
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The dataset that appear to better capture the patients’ likelihood of having 
complications is the rate of change.   
Table 5.1 Time series fuzzy clustering results 
 
Table 5.2 Time series fuzzy C-Means clustering results 
 
Classification
Fuzzy Logic                          
(Linear Interpolation)
Fuzzy Logic                                          
(Linear Interpolation 12 Hours)
Fuzzy Logic                                          
(Linear Interpolation 24 Hours)
Fuzzy Logic                   
(Rate of Change)
Type 1 in Cluster 1 0.55 0.45 0.54 0.27
Type 2 in Cluster 1 0.59 0.56 0.56 0.29
Type 3 in Cluster 1 1.00 1.00 1.00 0.60
Type 4 in Cluster 1 1.00 0.75 1.00 1.00
Type 1 in Cluster 2 0.45 0.55 0.46 0.73
Type 2 in Cluster 2 0.41 0.44 0.44 0.71
Type 3 in Cluster 2 0.00 0.00 0.00 0.40
Type 4 in Cluster 2 0.00 0.25 0.00 0.00
Classification
Fuzzy Logic                                 
(Rate of Change 12 Hours)
Fuzzy Logic                                   
(Rate of Change 12 Hours)
Fuzzy Logic                              
(Segments)
Fuzzy Logic                 
(Time Intervals)
Type 1 in Cluster 1 0.27 0.27 0.48 0.55
Type 2 in Cluster 1 0.29 0.29 0.51 0.65
Type 3 in Cluster 1 0.60 0.60 1.00 1.00
Type 4 in Cluster 1 1.00 1.00 0.75 1.00
Type 1 in Cluster 2 0.73 0.73 0.52 0.45
Type 2 in Cluster 2 0.71 0.71 0.49 0.35
Type 3 in Cluster 2 0.40 0.40 0.00 0.00
Type 4 in Cluster 2 0.00 0.00 0.25 0.00
Classification
Fuzzy Logic C-Means                          
(Linear Interpolation)
Fuzzy Logic C-Means                                                  
(Linear Interpoaltion 12 Hours)
Fuzzy Logic C-Means                                                  
(Linear Interpoaltion 24 Hours)
Fuzzy Logic C-Means                       
(Rate of Change)
Type 1 in Cluster 1 0.36 0.70 0.61 1.00
Type 2 in Cluster 1 0.34 0.71 0.69 0.99
Type 3 in Cluster 1 0.00 1.00 1.00 1.00
Type 4 in Cluster 1 0.25 0.75 0.75 1.00
Type 1 in Cluster 2 0.64 0.30 0.39 0.00
Type 2 in Cluster 2 0.66 0.29 0.31 0.01
Type 3 in Cluster 2 1.00 0.00 0.00 0.00
Type 4 in Cluster 2 0.75 0.25 0.25 0.00
Classification
Fuzzy Logic C-Means                                          
(Rate of Change 12 Hours)
Fuzzy Logic C-Means                                            
(Rate of Change 12 Hours)
Fuzzy Logic C-Means                    
(Segments)
Fuzzy Logic C-Means                          
(Time Intervals)
Type 1 in Cluster 1 1.00 1.00 0.66 0.56
Type 2 in Cluster 1 0.99 0.99 0.68 0.69
Type 3 in Cluster 1 1.00 1.00 1.00 1.00
Type 4 in Cluster 1 1.00 1.00 0.75 0.75
Type 1 in Cluster 2 0.00 0.00 0.34 0.44
Type 2 in Cluster 2 0.01 0.01 0.32 0.61
Type 3 in Cluster 2 0.00 0.00 0.00 0.00
Type 4 in Cluster 2 0.00 0.00 0.25 1.00
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Table 5.3 Time series fuzzy K-Means clustering results 
 
When it is used around of 70% of the patients who survive are classified on the same 
group and just a 40% of the patients who died after complications where also classified 
on that group. The results above show that when using fuzzy K-Means and fuzzy C-
means the majority of the patients were mostly classified in the same cluster. This 
classification maybe due to the fact that all patients’ groups presented a similar behavior 
during the drop phase and during the recovery phase, thus the methods are unable to 
determine differences on the time series.  Most of the patients type 4 were classified 
together due to their similarities in the steepness of their slope during the drop phase.  
This classification was expected since the slopes during this phase appear to be steeper 
than for the other patients in other groups.   
The best performance of the methods is achieved when the rate of change every 12 
hours is used to generate the clusters, since better membership values are obtained.  All 
the patients who survived the perioperative period are included in the cluster.  Also when 
Classification
Fuzzy Logic K-Means                          
(Linear Interpolation)
Fuzzy Logic K-Means                                                  
(Linear Interpolation 12 Hours)
Fuzzy Logic K-Means                                                  
(Linear Interpolation 24 Hours)
Fuzzy Logic K-Means                        
(Rate of Change)
Type 1 in Cluster 1 0.27 0.22 0.28 0.00
Type 2 in Cluster 1 0.21 0.14 0.23 0.01
Type 3 in Cluster 1 0.00 0.00 0.00 0.00
Type 4 in Cluster 1 0.00 0.25 0.25 0.00
Type 1 in Cluster 2 0.73 0.78 0.72 1.00
Type 2 in Cluster 2 0.79 0.86 0.77 0.99
Type 3 in Cluster 2 1.00 1.00 1.00 1.00
Type 4 in Cluster 2 1.00 0.75 0.75 1.00
Classification
Fuzzy Logic K-Means                                          
(Rate of Change 12 Hours)
Fuzzy Logic K-Means                                            
(Rate of Change 12 Hours)
Fuzzy Logic K-Means                    
(Segments)
Fuzzy Logic K-Means                          
(Time Intervals)
Type 1 in Cluster 1 0.00 0.00 0.77 0.38
Type 2 in Cluster 1 0.00 0.00 0.80 0.23
Type 3 in Cluster 1 0.00 0.00 1.00 0.00
Type 4 in Cluster 1 0.00 0.00 0.75 0.25
Type 1 in Cluster 2 0.00 0.00 0.23 0.62
Type 2 in Cluster 2 0.00 0.00 0.20 0.77
Type 3 in Cluster 2 0.00 0.00 0.00 1.00
Type 4 in Cluster 2 0.00 0.00 0.25 0.75
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the clusters are created less overlapping is observed when fuzzy clustering techniques are 
used.   
Overall the three fuzzy methods utilized did not fully capture differences between 
patient types 1 and 2. Patients type 1 and 2 presented very similar trends on their 
laboratory tests results even after the drop phase.  For most of these patients it is very 
difficult to identify whether they have complications or not just by interpreting their 
platelet count or plasma calcium.  This is due to the different type of complications that 
are reported during patients’ stay in the clinic.  Many of the detected complications are 
not directly related to the levels of plasma calcium or platelet count; it is possible that the 
attending physicians identified them based on a different test, or based experience.  Some 
of the complications found on the patient population were reported as follows in the 
information system: digestive system complication, pneumonia, arterial fibrillation, 
systemic sepsis, urinary tract infection, pleural effusion, anemia, chest pain, stroke, 
pulmonary insufficiency, acute renal failure, tachycardia, hypertension, reoperation for 
bleeding, myocardial infarction, intubation, cardiac arrest, metabolic encephalopathy, 
aortic valve disorder, acute lung edema, tracheotomy, asphyxia, and urine retention (more 
than 50 different types of complications were listed on the database).  
Because the nature of these complications lies with the reaction of the different 
patients to the surgery, it is difficult to timely identify all of them with the information 
provided by just two tests. However, since low platelet count, or a quick drop on it, are 
related to complications such as internal bleeding, physicians could anticipate platelet 
count related complications if its levels are regularly checked to confirm whether the 
results are within the reference range and if the slope do not appear to be too steep.  The 
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same conclusion can be draw for plasma calcium due to? its relationship with the 
mechanical function of the heart.  Therefore complications related with mechanical 
failure such as strokes and chest pains can be anticipated by monitoring plasma calcium 
levels.  
Regarding the number of clusters, several tests have been performed to evaluate what 
should be the appropriate number of clusters that should be included on the study.  It 
would be expected that, since the patients were classified in 4 categories, type 1, 2, 3 and 
4, the best scenario is the one where all patients from the same type were classified in a 
different cluster with membership values close to 1.  If 4 clusters are constructed, all the 
membership values tend to be equal to 0.25, which means that there is equal probability 
to the patient to belong to each cluster.  A similar situation occurred when 3 clusters are 
designed, but in this case the membership values were close to 0.33.   Figures 5.1 and 5.2 
show the performance of the clustering techniques for one of the resulting datasets.  It is 
notice that when 2 clusters are used the overlapping is less. 
  
Figure 5.1 Fuzzy Logic Clustering (linear interpolation 12 hours), K=2 
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Figure 5.2 Fuzzy Logic Clustering (linear interpolation 12 hours), K=3 
 
When K is increased, more fuzziness is introduced without increase the interpretation 
power.  Based on the experimentation, best results were obtained when the rate of change 
is used instead of just the actual laboratory test result data.  It is important to highlight 
that even though one of the objectives in implementing fuzzy logic is to obtain some 
fuzziness, if K increases over 2 the results will not provide us with useful information 
about the behavior of the patients. The same results are obtained when other methods are 
used. 
Since the fuzziness is too high when more than 2 clusters are used, the best scenario 
is when patients who did not die where classify in the same group and the remaining in 
the other.  However, since there are similarities between patients who died after 
complications and the ones who did not die after complications this goal may be partially 
achievable.   
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Further research efforts should include more tests in the analysis to find their key 
features that help physicians in better detect suspicious patterns associated to 
complications during patients’ recovery after cardiovascular surgery. 
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Chapter 6: Conclusions and Future Work 
 
 
 
The analysis of postsurgical plasma calcium provides valuable information to assist 
physicians while conducting patient monitoring.   Plasma calcium tests results should be 
compared against the reference range to identify any signal that suggests a complication 
on patient condition.  However, every time a test result is analyzed it should to be 
associated to the instance when the sample was taken. In this way the physician 
determines to which period the test corresponds, decreasing (drop phase) or back to 
normal levels (in the case of plasma calcium, around the 7th day after surgery).     
It is expected that patients experience a consistent drop in plasma calcium and platelet 
count during the perioperative period.  The average length of this period on patients who 
did not experienced complications is around 1 day for plasma calcium and 2 days for 
platelet count, indicating that at the end of the second day after surgery both results 
should show an increasing trend.  If the test results continue dropping, it may indicate 
complications on the patient’s condition. 
The identification of different phases on patient recovery after cardiovascular surgery 
(drop, recovery and stabilization phase) would help physicians to timely identify unsafe 
patterns in plasma calcium and platelet count, associated to each of these phases.  These 
unsafe patters in both tests may be used as indicators of complications on the patient’s 
condition.  It was shown that all the patients behave fairly the same during the drop 
phase, since their plasma calcium levels, platelet count, T-CaDP-min and T-PDP-min are 
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statistically the same. However, the values of PDP-min and CaDP-min become a baseline to 
assess patient recovery.  It is important to mention that all the patients that reached an 
initial minimum in their test results, and then had recurring drops during the recovery 
phase, where reported as patients experiencing complications in the NSQIP records.  
These complications were associated to different causes, so it is difficult to identify 
whether the complication was mild or severe, or its effect on the patient’s outcome.   
Several patients had more than one complication during their stay on the clinic. The 
same patient could present episodes of tachycardia, sepsis, anemia or some other 
complication at the same time or during his stay in the clinic. Yet what the records do not 
show is the severity of the complication, and as a consequence, the real cause of the 
complication that made the patient stay longer than the expected time in the clinic or die 
is not identifiable.  Besides, the variety of the possible complications and their 
interactions make even more difficult to really understand the relationship of variations 
on test results and a specific complication. 
It is also important to highlight that variations on laboratory test can be correlated 
over time.  After performing a cross correlation analysis of the time series of test results 
of plasma calcium and ionized calcium, it was found a fairly high positive correlation 
(0.4), between both (plasma albumin and ionized calcium) even though there are several 
factors that affect the natural fall in both tests. For example the administration of free 
calcium intravenously during surgery, creates a peak on the ionized calcium results’ time 
series.   
The complications reported by physicians during the patient’s stay in the clinic differ 
among patients. This creates a problem if physicians want to will be able to timely 
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identify them all, since not all of them can be easily detected by interpreting a single 
blood test.  In addition, many of the detected complications are not directly related to the 
levels of a single test, instead they could be only be identified by the concurrent analysis 
of several pieces of information from blood test results, radiographies, among other 
screening procedures. However, the correct analysis of the appropriate indicator can be 
very useful in identifying complications on patients’ condition.  In the case of the 
population of study, the analysis of plasma calcium provides a good performance in 
detecting possible complications on patient’s condition, if a transformation is performed 
on the data (calculation of the rate of change every 12 hours).   
It is necessary to perform a deeper analysis on the data to increase the level of 
understanding of how to timely identify a complication on a patient.  The data from the 
NSQIP allow us to know the set of complications that a patient suffered during his 
recovery, which could further help to segment the analyses by complication type to better 
profile the trends of each test included on the CBC and BMP. Also, data from the 
JAHVA includes information about patient’s demographics that could provide with 
valuable information to construct a more comprehensive profile of the expected condition 
of a patient of a specific race, age and gender at the moment of the detection of a specific 
complication during the recovery process. 
Since almost all patients included on this study that suffered complications had more 
than one, it is likely that many of these complications triggered others.  It is important to 
understand the physiological process associated to the appearance of complication on a 
patient to be able to anticipate it effectively.  For example, a low level of white cells 
could create the perfect situation for the appearance of infections of different kind that 
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could end with the patient death.  Thus, key tests should be identified since they are 
markers of many of the most common complications, such as platelet count is clearly 
associated to bleeding, and then find the data transformation that better helps to extract 
valuable information from the data sets.      
Future work will address the analysis of other laboratory tests that present a negative 
acute response to the surgery to identify if the behavior of the tests studied on this 
research is similar to the behavior of other test results.  Also, the variations on plasma 
calcium, and other laboratory tests, may be associated to patients’ characteristics such as 
race, age and gender.  Further studies could be focused on the analysis of the relationship 
of these attributes and the recovery process of patients after undergoing cardiovascular 
surgery.   
The methodology presented on this work can be replicated to analyze laboratory tests 
results associated to the monitoring process of patients after any surgical procedure.  The 
main challenge for the user is to determine the appropriate set of tests that should be 
included on the analysis of patient postoperative condition.    
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